Article
Cyclin E1 protein is stabilized in BRCA1 mutated breast cancers leading to synergy between…
medRxiv · 2020 · Aziz, D.; Portman, N.; Fernandez, K.; Lee, C.; Alexandrou, S.; Llop-Guevara, A.; Yong, A.; Wilkinson, A.; Sergio, C. M.; Ferraro, D.; Etemadmoghadam, D.; Bowtell, D.; Investigators, k.; Serra, V.; Waring, P.; Lim, E.; Caldon, C. E.
Key facts
| Title | Cyclin E1 protein is stabilized in BRCA1 mutated breast cancers leading to synergy between CDK2 and PARP inhibitors |
|---|---|
| First author | Aziz, D.; Portman, N.; Fernandez, K.; Lee, C.; Alexandrou, S.; Llop-Guevara, A.; Yong, A.; Wilkinson, A.; Sergio, C. M.; Ferraro, D.; Etemadmoghadam, D.; Bowtell, D.; Investigators, k.; Serra, V.; Waring, P.; Lim, E.; Caldon, C. E. |
| Journal | medRxiv |
| Published | Jan 30, 2020 |
| DOI | 10.1101/2020.01.29.911883 |
| Product codes mentioned | GIA, IBG, KIR, NJT, PPM |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1